期刊文献+

6,7-二甲氧基-4-芳胺基喹唑啉衍生物的合成与活性筛选 被引量:7

Synthesis and Bioactivity of 6,7-Dimethoxy-Quinazoline-4-Arylamine Derivatives
暂未订购
导出
摘要 目的合成6,7-二甲氧基-4-芳胺基喹唑啉衍生物及其抗肿瘤活性筛选。方法以2-氨基-4,5-二甲氧基苯甲酸和醋酸甲脒为原料,合成了10个4位芳胺取代的6,7-二甲氧基喹唑啉衍生物,利用酶联免疫吸附分析法(ELISA)PTK-101试剂盒并对化合物进行活性筛选。结果合成的化合物经IR,1H-NMR,MS结构表征。初步的生物活性测试表明,这类化合物对表皮生长因子受体(EGFR)酪氨酸激酶有明显的抑制活性。其苯环4′位的取代基变化对活性具有显著影响。结论6,7-二甲氧基-4-芳胺基喹唑啉衍生物可能会在治疗肿瘤特别是非小细胞肺癌方面发挥更大。 OBJECTIVE To study the synthesis of 4-arylamino substituted 6,7-dimethoxylqui-nazoline and its derivatives.METHOD 4-Arylamino substituted 6,7-dimethoxylquinzoline were synthesized by 2-amion-4,5-dimethoxylbenzoicacid and formamidine acetate.RESULT The structures of the compounds were confirmed by IR, ^1H-NMR MS and melting point. The bioassay results indicated that some of the compounds show certain inhibition against EGFR-TK. In addition,varying substituents on 4-arylaniline in the compormd leadsed to different bioactivities.CONCLUSION 4-Arylamino substituted 6,7-dimethoxylquinazoline and the its derivatives may develop a new drug against non small cell lung cane-er.
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第22期1748-1752,共5页 Chinese Pharmaceutical Journal
基金 浙江省科技厅重点项目资助(2004C21019)
关键词 喹唑啉衍生物 EGFR抑制剂 生物活性 quinazoline derivatives EGFR inhibitors bioactiveity
  • 相关文献

参考文献9

  • 1PATARCA R. Protein phosphorylation and dephosphorylation in physiologic and oneologie processes [ J ]. Crit Rev Oncog, 1996, 7:343-432.
  • 2KOLIBABA K S, DRUKER B J. Protein tyrosine kiuases and cancer [ J ]. Biochim Biophys Actor, 1997,1333 : 217-248.
  • 3FORTUNATO C, GIAMPAOI.O T. A novel approach in The treatment of cancer: targeting the epidermal growth factor receptor [ J ]. Clin Cancer Res ,2001,7 (10) :2958-2970.
  • 4REWCASTLE G W, DENN Y W A, BRIDGES A J ,et al. Synthesis and structure-activity relation,;hips for 4-[ (phenylmethyl) amino]- and 4-(phenylamino) quinazolins as potent adenosine 5'- triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth faclor receptor[ J ]. J Med Chem, 1995, 38(18) :3482-3487.
  • 5REWCASTLE G W,PALMER B D,BRIDGES A J,et al. Tyrosine klnase inhibitor 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP binding site inhibitor of t he Tyrosine kinase function of the epidermal[ growth factor receptor [J]. J Med Chem,1996 ,39( 4 ) :918-928.
  • 6BRIDGE A J,MCMICHAEL A.ItOLLIS H D,et al. Tyrosine kinase inhibitors. 8. An unusually steep strueture-aetivity relationship for analogues of 4- (3-bromoanilino) -6,7-dimethoxyqninazoline ( PD153035 ) ,a potent inhibitor of the epidermal growth factor receptor [ J].J Med Chem, 1996,39:267-276.
  • 7ROCCO S A.BARBARINI J E,RITTNET R. Syutheses of some 4-anilinoquinazoline derivatives [ J ]. Synthesis .2004,429-435.
  • 8MYERS M R,SPADA A P, MAGUIREM A P. Aryl and heleroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase . Persons,. US Pat. 5710158 [ P]. 1985, 23 ( 9 ) : 2375-2386.
  • 9UCKUN F M, LIU X P, NARLA R K. 4-( 3'-Bromo4'hydroxylphenyl)- amino-6,7-dimethoxyquinazotine: a novel quinazoline derivative with potenl cytotoxie activily against human glioblasloma cells [ J ] . J Clinical Cancer Research, 1998,6 (4) : 1405- 1414.

同被引文献99

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部